Protocollo N 2014 - Benign Prostatic Hyperplasia

NCT ID: NCT06182189

Last Updated: 2023-12-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

8000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-12-01

Study Completion Date

2034-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective observational study on the quality of life of patients with BPH under medical therapy and/or undergoing surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Prospective observational study on the quality of life of patients with BPH under medical therapy and/or undergoing surgery.

Data relating to the clinical conditions (state of the disease, psychological and related to the quality of life) of patients suffering from BPH under medical therapy and/or undergoing surgery will be collected within a specially designed database which will allow us to easily and secure extraction of data used for statistical analyzes in clinical research.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Benign Prostatic Hyperplasia

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

benign prostatic hyperplasia; urology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with a benign prostatic hyperplasia condition

Patients with a benign prostatic hyperplasia condition

Observation of patients with a benign prostatic hyperplasia condition

Intervention Type OTHER

Observation of patients with a benign prostatic hyperplasia condition who have undergone surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observation of patients with a benign prostatic hyperplasia condition

Observation of patients with a benign prostatic hyperplasia condition who have undergone surgery

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* subjects suffering from benign prostatic hyperplasia undergoing medical therapy and/or undergoing surgery
* subjects \>= 18 years old
* signature of informed consent

Exclusion Criteria

* subjects \< 18 years
* presence of mental or physical disability that may prevent the patient from answering the questionnaires.
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

IRCCS San Raffaele

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Andrea Salonia

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Andrea Salonia, MD

Role: PRINCIPAL_INVESTIGATOR

IRCCS Ospedale San Raffaele

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IRCCS Ospedale San Raffaele

Milan, Lombardy, Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Andrea Salonia, MD

Role: CONTACT

Phone: 02 2643 5661

Email: [email protected]

Alessia d'Arma, MSc

Role: CONTACT

Phone: 02 2643 5506

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Alessia d'Arma, MSc

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2014 - IPB

Identifier Type: -

Identifier Source: org_study_id